Flash Grant Frequently Asked Questions

Return to the Flash Grant webpage.

  • What is the definition of “disruptive technology” for the Flash Grants?

    Disruptive life sciences technologies are those that may significantly alter the way a market or industry functions, how a product is developed or sold, or how a disease is treated. Disruptive technologies may also displace or render previous products, methods, and business model obsolete.

  • What is the definition of “translational research phase” of development for the Flash Grants?
    The translational research phase of development for life science technologies is the one immediately following the conclusion of the basic research phase (the “how does it work” phase of research) as it enters the earliest stages of product development (the “what is the product/market/route towards commercialization” phase). The translational research phase of development takes laboratory bench-scale research findings and brings them through to the in vivo or clinical trial stage of development.

  • Can you give some examples of Flash Grant projects?

    Examples of Flash Grant projects include:

    • Core facility fees or instrumentation usage fees
    • Proof-of-concept and feasibility studies for disruptive technologies/discoveries
    • Compound screening against a validated target; access to compound libraries
    • Prototype development
    • Scale-up pilot studies
    • Optimization studies
    • Algorithm development and validation
    • Precision feed ingredient studies
    • Plant-based products influenced by environmental growing conditions
    • Quality assurance of genetic or biostimulant agricultural measures
  • Can commercial/business development projects be funded with a Flash grant?
    Commercial/business development activities can be conducted as part of a Flash grant, but cannot be the sole activities proposed and undertaken with Flash grant funding. Commercial/business data to be gathered may include voice of customer outreach, IP landscaping, market and competitor data, reimbursement strategies, regulatory approval strategies, etc.

  • How do you define "precision health"?

    Precision health is a multi-disciplinary health care approach that utilizes knowledge about an individual’s genome, environment, lifestyle, and applicable technologic innovation to more precisely and efficiently predict risk, diagnose disease, target therapies, inform health care decisions, and personalize health and wellness plans.


    Precision Health combines data about an individual’s genes, environment, and lifestyle with innovation and drivers partnerships to more precisely predict and diagnose disease, target therapies, and personalize health and wellness plans.

  • How do you define "digital- and data-driven" technologies?
    Digital- and data-driven life science technologies are technologies that exist at the convergence of the life sciences with breakthrough electronic data collection/storage/analysis platforms. The Flash Grant may be used to fund the initial development or validation of such a platform that is novel and directly addresses an unmet, life science-related need.


    Data-driven life science technologies include but are not limited to:

    • FAIR Data Practices
      • Indexing
      • Metadata capture
      • Security, privacy, consenting, and IP protection
    • Computational Biology
      • Bioinformatics
      • Macromolecular structures
      • Genome sequences
      • Functional genetics
      • Macromolecular geometry
      • Phylogenetic tree construction
      • Protein structure/function
      • Gene finding
      • Expression data analysis
    • Biostatistics
      • Genome-wide association studies
      • Transcriptome-wide association studies
    • Data Science
      • Cloud computing
      • Machine learning (ML) and artificial intelligence (AI)
      • Lab automation